Site Management/Investigator Payments Featured Articles
-
What SIP Gets Right And Where It Still Falls Short
9/4/2026
SIP users Sophie Haynes and Vicki Alvarez identify features that provide value but question whether the platform eliminates enough work to justify its setup demands, repetitive processes, and usability challenges.
-
5 Ways To Enrich The Clinical Trial Ecosystem
9/4/2026
Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.
-
The SIP Problem Is Bigger Than SIP
9/1/2026
Sites continue to struggle with duplicated administrative work across too many sponsor and CRO systems. Current SIP users cite real frustrations with the platform, but their experiences also suggest the original goal of a shared, standardized site-information system remains highly relevant.
-
How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure
9/1/2026
By pairing donor priorities with research needs at Children's National, Milken Institute SPARC is turning philanthropy into faster trials, stronger infrastructure, and long-term care goals.
-
The Pharmacy Benefit No One Is Managing: Clinical Research As A Care Option
8/28/2026
Pharmacies could make trials more accessible — if they preserve patient trust while research partners handle the operational burden.
-
Planning A Global Clinical Trial With The Right Sites, Not The Most Sites
8/27/2026
Less is more for Yi Larson and the team at Excursion Therapeutics, which opted to build right site network — not the largest one — for its Phase 2 trial.
-
Building SIP Was The Hard Part
8/26/2026
Charlie Semenchuk and Jeff Ventimiglia helped turn the ambitious vision for the Shared Investigator Platform into reality. They look back at SIP’s technical challenges, competing stakeholder needs, site burden, and what the experience can still teach an industry wrestling with many of the same problems today.
-
The Big Idea Behind The Creation Of SIP
8/20/2026
Jackie Kent, Lisa Moneymaker, and Jeanette Teague were among the early architects of the Shared Investigator Platform (SIP). In part one of this four-part series, they discuss SIP’s ambitious origins, the challenges of getting competing sponsors to collaborate, and why broad adoption was critical to delivering on its promise of reducing site burden.
-
Don't Accept This Site-Level Start-Up Bottleneck— Instead, Learn How To Stop It
8/10/2026
Combining investigator meetings and SIVs can cut site activation timelines in half — if sponsors build a compliance-sound case and involve QA early.
-
Delays At The Handoff: Where Breakdowns Occur Among The Sponsor, CRO, And Site
7/23/2026
Consultant Jason C. Bork identifies 10 of the most common points at which a trial can break down before and after patient recruitment.